DK1135140T3 - Ibandronsyre til fremme af osseointegration af endoproteser - Google Patents

Ibandronsyre til fremme af osseointegration af endoproteser

Info

Publication number
DK1135140T3
DK1135140T3 DK99958135T DK99958135T DK1135140T3 DK 1135140 T3 DK1135140 T3 DK 1135140T3 DK 99958135 T DK99958135 T DK 99958135T DK 99958135 T DK99958135 T DK 99958135T DK 1135140 T3 DK1135140 T3 DK 1135140T3
Authority
DK
Denmark
Prior art keywords
endoprostheses
ibandronic acid
promote osseointegration
osseointegration
promote
Prior art date
Application number
DK99958135T
Other languages
Danish (da)
English (en)
Inventor
Frieder Bauss
Andreas A Kurth
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1135140T3 publication Critical patent/DK1135140T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
DK99958135T 1998-12-04 1999-11-29 Ibandronsyre til fremme af osseointegration af endoproteser DK1135140T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855976 1998-12-04
PCT/EP1999/009252 WO2000033849A1 (en) 1998-12-04 1999-11-29 Use of ibandronate for promoting osseointegration of endoprostheses

Publications (1)

Publication Number Publication Date
DK1135140T3 true DK1135140T3 (da) 2005-12-19

Family

ID=7889968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958135T DK1135140T3 (da) 1998-12-04 1999-11-29 Ibandronsyre til fremme af osseointegration af endoproteser

Country Status (17)

Country Link
US (1) US6680307B1 (zh)
EP (2) EP1135140B1 (zh)
JP (1) JP3793023B2 (zh)
KR (1) KR100453779B1 (zh)
CN (1) CN1173704C (zh)
AR (1) AR020017A1 (zh)
AT (1) ATE303153T1 (zh)
AU (1) AU756540B2 (zh)
BR (1) BR9915927A (zh)
CA (1) CA2353528C (zh)
DE (1) DE69927048T2 (zh)
DK (1) DK1135140T3 (zh)
ES (1) ES2247842T3 (zh)
PT (1) PT1135140E (zh)
TR (1) TR200101546T2 (zh)
WO (1) WO2000033849A1 (zh)
ZA (1) ZA200104140B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004038A1 (en) * 2000-07-12 2002-01-17 Hopital Orthopedique De La Suisse Romande Active biocoating for bone implant
EP1228761A3 (en) * 2001-02-01 2003-01-15 Riderway Corporation Liquid pharmaceutical composition for treating bone diseases
TWI349553B (en) * 2001-12-21 2011-10-01 Procter & Gamble Kit and use of bisphosphonate for treating high bone turnover
MXPA04009586A (es) * 2002-05-10 2005-01-11 Hoffmann La Roche Acidos bisfosfonicos para el tratamiento y prevencion de la osteoporosis.
SI1596870T2 (sl) * 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
CA2594717C (en) * 2005-02-01 2015-01-20 F. Hoffmann-La Roche Ag Ibandronate polymorph b
BRPI0607092A2 (pt) * 2005-02-01 2009-08-04 Hoffmann La Roche polimorfo cristalino de monoidrato de sal monossódico de ácido 3-(n-metil-n-pentil) amino-1-hidroxipropano-1, 1-difosfÈnico, ibandronato, processo para a preparação de um polimorfo de ibandronato cristalino, e composição farmacêutica que o compreende
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
WO1994014455A1 (en) 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
WO1996039107A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
CA2274789A1 (en) * 1996-12-13 1998-06-18 Zymogenetics, Inc. Compositions and methods for stimulating bone growth

Also Published As

Publication number Publication date
ES2247842T3 (es) 2006-03-01
WO2000033849A1 (en) 2000-06-15
KR20010093137A (ko) 2001-10-27
DE69927048D1 (de) 2005-10-06
CA2353528C (en) 2007-04-24
DE69927048T2 (de) 2006-06-08
ATE303153T1 (de) 2005-09-15
EP1135140A1 (en) 2001-09-26
KR100453779B1 (ko) 2004-10-20
ZA200104140B (en) 2002-08-21
US6680307B1 (en) 2004-01-20
JP3793023B2 (ja) 2006-07-05
EP1614422A2 (en) 2006-01-11
AU1557700A (en) 2000-06-26
EP1614422A3 (en) 2009-02-18
BR9915927A (pt) 2001-08-21
CN1329495A (zh) 2002-01-02
CN1173704C (zh) 2004-11-03
EP1135140B1 (en) 2005-08-31
JP2002531509A (ja) 2002-09-24
CA2353528A1 (en) 2000-06-15
AR020017A1 (es) 2002-03-27
TR200101546T2 (tr) 2001-11-21
PT1135140E (pt) 2005-10-31
AU756540B2 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
ID22508A (id) Trokar untuk memasukkan implant-implant
DE60026734D1 (de) Brücke zur can-tcp/ip-verbindung
DK0980250T3 (da) Planteekstrakter til behandling af forøget knogleresorption
CY2006003I1 (el) Χρηση δαπτομυκινης
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
PT891776E (pt) Composicoes de simeticona/fosfato de calcio anidro
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
AR027907A1 (es) Composicion de liberacion controlada
NO20020185L (no) Formuleringer av IL-11
DE69837668D1 (de) Feste zusammensetzungen zur verminderung der zahnerosion
DK0866069T3 (da) Fremstilling af ascorbylmonophosphater
ATE279114T1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
DE60038118D1 (de) Formulierungen von wachstumshormonen
DK1135140T3 (da) Ibandronsyre til fremme af osseointegration af endoproteser
DK0875579T3 (da) Fremstilling af L(+)-laktat
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DE60039965D1 (de) Zusammensetzung zur erwerbung von immunologischer toleranz
DE69901243T2 (de) Artikulator zur herstellung von zahnärztlichen prothesen
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DK1165483T3 (da) Fremgangsmåde til fremstilling af carbonylfluorid